Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Kristin Ladell
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Kelly L Miners
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Morgan Marsden
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Lucy Chapman
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Anna Cardus Figueras
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Jake Scott
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom
Robert Andrews
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Simon Clare
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom
Valeriia V Kriukova
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation; Institute of Clinical Molecular Biology, Christian-Albrecht-University of Kiel, Kiel, Germany
Ksenia R Lupyr
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation; Institute of Translational Medicine, Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation
Olga V Britanova
Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation; Institute of Clinical Molecular Biology, Christian-Albrecht-University of Kiel, Kiel, Germany; Institute of Translational Medicine, Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation
David R Withers
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
Simon A Jones
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Dmitriy M Chudakov
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation; Genomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation; Institute of Translational Medicine, Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation; Abu Dhabi Stem Cell Center, Al Muntazah, United Arab Emirates
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom; Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom
Inhibitory CD4+ T cells have been linked with suboptimal immune responses against cancer and pathogen chronicity. However, the mechanisms that underpin the development of these regulatory cells, especially in the context of ongoing antigen exposure, have remained obscure. To address this knowledge gap, we undertook a comprehensive functional, phenotypic, and transcriptomic analysis of interleukin (IL)-10-producing CD4+ T cells induced by chronic infection with murine cytomegalovirus (MCMV). We identified these cells as clonally expanded and highly differentiated TH1-like cells that developed in a T-bet-dependent manner and coexpressed arginase-1 (Arg1), which promotes the catalytic breakdown of L-arginine. Mice lacking Arg1-expressing CD4+ T cells exhibited more robust antiviral immunity and were better able to control MCMV. Conditional deletion of T-bet in the CD4+ lineage suppressed the development of these inhibitory cells and also enhanced immune control of MCMV. Collectively, these data elucidated the ontogeny of IL-10-producing CD4+ T cells and revealed a previously unappreciated mechanism of immune regulation, whereby viral persistence was facilitated by the site-specific delivery of Arg1.